Using an array of techniques, including RNA sequencing and
targeted gene expression profiling, the researchers searched for links between gene activity and protein production in these tumors and the clinical outcomes of patients.
Not exact matches
The patterns of these polymorphic
genes and their
expression profiles comprise the molecular signatures of unique pathophenotypes, offering the promise of diagnostic, prognostic, and therapeutic specificity; the definition of disease becomes «personalized», as does its specific therapeutic
targets.
The approach to
target validation utilizes RNAi, CRISPR, and ORF
expression platforms to genetically perturb candidate
target gene expression in relevant cancer cell lines, and then
profile the resulting phenotypic changes with regard to their effect on various biochemical pathways.
As outlined below, we used a microfluidic quantitative PCR (qPCR) system to elucidate the
gene expression profiles of individual human oocytes and small numbers of cumulus cells using a combination of a large number of samples and
targets [12], and then extended our studies via the use of parthenogenesis, in conjunction with
gene expression profiling, as a functional assay of cytoplasmic maturation of oocytes.
With DriverMap, Cellecta offers a novel, comprehensive end - to - end service portfolio for identifying differential
gene expression, mapping of clinically actionable mutations in RNA, detecting cellular composition, and
profiling immunotherapy
targets.
Dr. Loftus's research has gone on to detail how SOX10 and its downstream
target gene MITF coordinately regulate
gene expression profiles associated with melanocyte differentiation.
«Simultaneous mutation detection, copy number measurement, and digital
gene expression profiling of high - grade serous ovarian cancer FFPE samples using Hyb & SeqTM
targeted sequencing technology»
Approximately 50 % of PTCL are unclassifiable and categorized as PTCL, not otherwise specified (PTCL - NOS).1 Using
gene expression profiling, PTCL - NOS lymphocytes can be distinguished from normal T lymphocytes, with deregulation of
genes involved in apoptosis, proliferation, cell adhesion, and transcription regulation.2 Two subgroups of PTCL - NOS have been identified, which are characterized by high
expression of either GATA3 or TBX21 / T - bet transcription factors and downstream
target genes.3 However, actionable biomarkers closely related to the pathogenic mechanism need to be further investigated and may become potential therapeutic
targets of PTCL - NOS. 4, 5
Robust prognostic
gene signatures and therapeutic
targets are difficult to derive from
expression profiling because of the significant heterogeneity within breast cancer (BC) subtypes.
The new Driver - Map ™ Human Genome - Wide
Gene Expression Profiling kit, is a targeted RNA expression profil
Expression Profiling kit, is a targeted RNA expression profili
Profiling kit, is a
targeted RNA
expression profil
expression profilingprofiling assay.